Drugs / naphazoline hydrocloride
last change Apr 2014 re-read 2 minutes ago

naphazoline hydrocloride

Developed for
allergic respiratory disease

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01533220 Comparator Jan → Aug 2013 allergic respiratory disease, influenza EMS Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as naphazoline hydrocloride ClinicalTrials.gov intervention name — accepted as the source's own label NCT01533220
Route Intranasal “02 drops into each nostril, 04 times a day for 03 days” NCT01533220